title: Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
abstract: Quantitative 2-[(18)F]fluoro-2-deoxy-D-glucose ([(18)F]FDG) positron emission tomography (PET) has been widely used to calculate glucose utilization in skeletal muscle. FDG-PET results depend partly on the lumped constant (LC), which accounts for the differences in the transport and phosphorylation between [(18)F]FDG and glucose. In this study, we estimated the LC for [(18)F]FDG directly in normal and in insulin-resistant obese subjects by combining FDG PET with the microdialysis technique. Eight obese [age 29.4 +/- 1.0 yr, body mass index (BMI) 33.6 +/- 1.0 kg/m(2)] and eight nonobese (age 25.0 +/- 1.0 yr, BMI 23.1 +/- 1.0 kg/m(2)) males were studied during euglycemic hyperinsulinemia (1 mU. kg(-1).min(-1) for 150 min). Muscle blood flow was measured using (15)O-labeled water and PET. Muscle [(18)F]FDG uptake (rGU(FDG)) was calculated with Patlak graphic analysis. Interstitial glucose concentration of the quadriceps femoris muscle was measured simultaneously with [(18)F]FDG scanning using microdialysis. Muscle glucose uptake (by microdialysis, rGU(MD)) was calculated by multiplying glucose extraction by regional muscle blood flow. A significant correlation was found between rGU(MD) and rGU(FDG) (r = 0.78, P < 0.01). The LC was determined as the ratio of the rGU(FDG) to the rGU(MD). The LC averaged 1.16 +/- 0.16 and was similar in the obese and nonobese subjects (1.15 +/- 0.11 vs. 1.16 +/- 0.07, respectively, not significant). In conclusion, the microdialysis technique can be reliably combined with FDG PET to measure glucose uptake in skeletal muscle. Direct measurements with these two independent techniques suggest an LC value of 1.2 for [(18)F]FDG in human skeletal muscle during insulin stimulation, and the LC appears not to be sensitive to insulin resistance.
authors.affiliation: Turku Positron Emission Tomography Center, Department of Internal Medicine, University of Gothenburg, 41345 Gothenburg, Sweden. papelto@utu.fi
authors.forename: P
authors.initials: P
authors.lastname: Peltoniemi
authors.forename: P
authors.initials: P
authors.lastname: Lönnroth
authors.forename: H
authors.initials: H
authors.lastname: Laine
authors.forename: V
authors.initials: V
authors.lastname: Oikonen
authors.forename: T
authors.initials: T
authors.lastname: Tolvanen
authors.forename: T
authors.initials: T
authors.lastname: Grönroos
authors.forename: L
authors.initials: L
authors.lastname: Strindberg
authors.forename: J
authors.initials: J
authors.lastname: Knuuti
authors.forename: P
authors.initials: P
authors.lastname: Nuutila
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D015309:Glucose Clamp Technique; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D007700:Kinetics; D017551:Microdialysis; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism*; D010766:Phosphorylation; D019275:Radiopharmaceuticals / Q000378:metabolism; D014055:Tomography, Emission-Computed
chemical_list: D001786:Blood Glucose; D005462:Fluorine Radioisotopes; D007328:Insulin; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005947:Glucose